Serge Fratte - Publications

Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO - PRODIGE 82).

Journal: BMC cancer

Published: May 24, 2023

Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 04, 2021

Interest of the Addition of Taxanes to Standard Treatment in First-Line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients.

Journal: Frontiers in oncology

Published: August 24, 2021

Narrow-band imaging versus Lugol chromoendoscopy for esophageal squamous cell cancer screening in normal endoscopic practice: randomized controlled trial.

Journal: Endoscopy

Published: July 22, 2020

Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 14, 2020

Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 06, 2018

Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 22, 2016

Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: January 15, 2016

Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 28, 2015

Prognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinoma.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: January 14, 2015

Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer.

Journal: Cancer chemotherapy and pharmacology

Published: February 17, 2014

Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy.

Journal: BMC gastroenterology

Published: August 09, 2013